Yoko Takiuchi Selected Research

Yoko Takiuchi Research Topics

Disease

4	Neoplasms (Cancer) 01/2019 - 01/2012
3	Multiple Myeloma 09/2021 - 01/2013
3	Lymphoma (Lymphomas) 03/2014 - 04/2010
2	POEMS Syndrome (Syndrome, POEMS) 05/2021 - 01/2010
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2018 - 04/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2014 - 04/2010
1	Epstein-Barr Virus Infections 04/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2021
1	Multi-centric Castleman's Disease 05/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2020
1	Disease Progression 04/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 04/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2019
1	Leukocytosis (Pleocytosis) 01/2019
1	Infections 01/2019
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Immunoglobulin Light-chain Amyloidosis 01/2013
1	Melena 01/2013
1	Carpal Tunnel Syndrome 11/2012
1	Heavy Chain Disease 01/2012
1	Dyspnea (Shortness of Breath) 01/2012
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2011
1	Septic Shock (Toxic Shock Syndrome) 01/2011
1	Tumor Lysis Syndrome 01/2011
1	Ascites 01/2011
1	Shock 10/2010
1	Rheumatoid Arthritis 10/2010
1	Diarrhea 10/2010
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 10/2010
1	Arthralgia (Joint Pain) 10/2010
1	Diabetes Mellitus 01/2010
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2010
1	Heart Failure 01/2010
1	Hemochromatosis (Bronze Diabetes) 01/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2009
1	Refractory Anemia with Excess of Blasts (RAEM) 10/2009
1	Pulmonary Alveolar Proteinosis 10/2009

Drug/Important Bio-Agent (IBA)

3	Immunoglobulin G (IgG)IBA 09/2021 - 11/2012
3	Etoposide (VP 16)FDA LinkGeneric 06/2020 - 04/2010
3	Methotrexate (Mexate)FDA LinkGeneric 06/2020 - 04/2010
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 10/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 01/2010
2	Vincristine (Oncovin)FDA LinkGeneric 06/2020 - 01/2011
2	Lenalidomide (CC 5013)FDA Link 04/2019 - 01/2013
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019 - 01/2019
2	Therapeutic UsesIBA 01/2013 - 10/2010
2	Amyloid (Amyloid Fibrils)IBA 01/2013 - 10/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2010 - 01/2010
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2020
1	sobuzoxaneIBA 06/2020
1	A-Form DNA (A-DNA)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2018
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2018
1	PP242IBA 01/2018
1	Everolimus FDA Link 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	MTOR InhibitorsIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	abacavir (Ziagen)FDA Link 04/2015
1	Bortezomib (Velcade)FDA Link 01/2013
1	Rituximab (Mabthera)FDA Link 01/2012
1	fludarabineIBA 01/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012
1	Surface Antigens (Surface Antigen)IBA 01/2011
1	Methylprednisolone FDA LinkGeneric 01/2011
1	SteroidsIBA 01/2011
1	Prednisolone (Predate)FDA LinkGeneric 10/2010
1	tocilizumab (atlizumab)FDA Link 10/2010
1	AA amyloidosisIBA 10/2010
1	Ifosfamide FDA LinkGeneric 04/2010
1	Asparaginase (Elspar)FDA Link 04/2010
1	Insulin (Novolin)FDA Link 01/2010
1	Thalidomide (Thalomid)FDA Link 01/2010
1	Surface-Active Agents (Surfactants)IBA 10/2009

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 06/2020 - 01/2010
2	Therapeutics 01/2011 - 01/2010
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2010 - 10/2009
1	Hematopoietic Stem Cell Transplantation 04/2022
1	Salvage Therapy 06/2020
1	Oral Administration 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2012
1	Critical Care (Surgical Intensive Care) 10/2010
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2010